Cargando…
TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- consensus recommendations by a Turkish multidisciplinary panel
In this review, we have attempted to share our 10 years’ clinical experience with aripiprazole use and switching from other antipsychotics to aripiprazole. There are various reasons for switching, including a partial or complete lack of efficacy, adverse side effects, and partial or noncompliance wi...
Autores principales: | Veznedaroglu, Baybars, Dilbaz, Nesrin, Uzun, Ozcan, Isik, Erdal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130089/ https://www.ncbi.nlm.nih.gov/pubmed/30210778 http://dx.doi.org/10.1177/2045125318772712 |
Ejemplares similares
-
Taiwan Expert Consensus Recommendations for Switching to Aripiprazole Long-Acting Once-Monthly in Patients with Schizophrenia
por: Liang, Chih-Sung, et al.
Publicado: (2021) -
Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole
por: Kohen, Izchak, et al.
Publicado: (2010) -
Biological conversion of aripiprazole lauroxil - An N-acyloxymethyl aripiprazole prodrug
por: Rohde, Morten, et al.
Publicado: (2014) -
Chlorine Atoms
of an Aripiprazole Molecule Control
the Geometry and Motion of Aripiprazole and Deschloro-aripiprazole
in Subdomain IIIA of Human Serum Albumin
por: Kawai, Akito, et al.
Publicado: (2022) -
Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
por: Kotorki, Paraskevi, et al.
Publicado: (2010)